Skip to main content
Chris Halloran

Professor Chris Halloran
BSc, MB ChB (commend), MD, FRCS (Eng), FRCS (Gen Surg), SFHEA, FRSCEd (ad hom)

Publications

Selected publications

  1. Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial (Journal article - 2017)
  2. Guidelines for the understanding and management of pain in chronic pancreatitis (Journal article - 2017)
  3. Pancreatic Anastomosis After Pancreatoduodenectomy: A Position Statement By The International Study Group Of Pancreatic Surgery (ISGPS) (Journal article - 2017)
  4. Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis (Journal article - 2016)
  5. What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses (Journal article - 2015)
  6. A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial. (Journal article - 2022)
  7. International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. (Journal article - 2020)
  8. Emerging Phenotype of Severe Acute Respiratory Syndrome-Coronavirus 2-associated Pancreatitis. (Journal article - 2020)
  9. Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections. (Journal article - 2021)
  10. The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis (Journal article - 2021)
What type of publication do you want to show?

2024

Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy: An International Cross-Sectional Multicenter Study.

Hendriks, T. E., Balduzzi, A., van Dieren, S., Suurmeijer, J. A., Salvia, R., Stoop, T. F., . . . International Study Group for Pancreatic Surgery (ISGPS). (2024). Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy: An International Cross-Sectional Multicenter Study.. Annals of surgery, 280(5), 728-733. doi:10.1097/sla.0000000000006473

DOI
10.1097/sla.0000000000006473
Journal article

Clinical and financial validation of the International Study Group for Pancreatic Surgery (ISGPS) definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study

Halloran, C. (2024). Clinical and financial validation of the International Study Group for Pancreatic Surgery (ISGPS) definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study. Annals of Surgery. doi:10.1097/SLA.0000000000006569

DOI
10.1097/SLA.0000000000006569
Journal article

Glycaemic control following total pancreatectomy: room for improvement?

Shapey, I. M., Alfred, J., Sharp, R., Whelan, P., Szatmary, P., Mann, K., . . . Baron, R. D. (2024). Glycaemic control following total pancreatectomy: room for improvement?. HPB : the official journal of the International Hepato Pancreato Biliary Association, 26(8), 1075-1078. doi:10.1016/j.hpb.2024.04.015

DOI
10.1016/j.hpb.2024.04.015
Journal article

Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus.

Barreto, S. G., Strobel, O., Salvia, R., Marchegiani, G., Wolfgang, C. L., Werner, J., . . . International Study Group for Pancreatic Surgery. (2024). Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus.. Annals of surgery. doi:10.1097/sla.0000000000006454

DOI
10.1097/sla.0000000000006454
Journal article

A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.

NIHR Global Health Research Unit on Global Surgery., & STARSurg Collaborative. (2024). A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.. The Lancet. Digital health, 6(7), e507-e519. doi:10.1016/s2589-7500(24)00065-7

DOI
10.1016/s2589-7500(24)00065-7
Journal article

Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.

Overbeek, K. A., Poulsen, J. L., Lanzillotta, M., Vinge-Holmquist, O., Macinga, P., Demirci, A. F., . . . PrescrAIP Study Group. (2024). Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(5), 994-1004.e10. doi:10.1016/j.cgh.2023.12.010

DOI
10.1016/j.cgh.2023.12.010
Journal article

Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.c.7075692

DOI
10.1158/0008-5472.c.7075692
Other

Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.c.7075692.v1

DOI
10.1158/0008-5472.c.7075692.v1
Other

Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224576.v1

DOI
10.1158/0008-5472.25224576.v1
Other

Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224576

DOI
10.1158/0008-5472.25224576
Other

Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224573

DOI
10.1158/0008-5472.25224573
Other

Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224573.v1

DOI
10.1158/0008-5472.25224573.v1
Other

Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224567

DOI
10.1158/0008-5472.25224567
Other

Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224567.v1

DOI
10.1158/0008-5472.25224567.v1
Other

Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224564

DOI
10.1158/0008-5472.25224564
Other

Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224564.v1

DOI
10.1158/0008-5472.25224564.v1
Other

Abstract PR02: Deep proteomics identifies novel biomarker candidates and molecular pathways of pancreatic cancer-related diabetes

Oldfield, L., Johnson, E., Gutiérrez, E. C., Stott, M., Greenhalf, W., Halloran, C., & Costello, E. (2024). Abstract PR02: Deep proteomics identifies novel biomarker candidates and molecular pathways of pancreatic cancer-related diabetes. Cancer Research, 84(2_Supplement), PR02. doi:10.1158/1538-7445.panca2023-pr02

DOI
10.1158/1538-7445.panca2023-pr02
Journal article

Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours

Freeman, P., Bellomo, G., Ireland, L., Abudula, M., Luckett, T., Oberst, M., . . . Mielgo, A. (n.d.). Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours. Frontiers in Immunology, 15. doi:10.3389/fimmu.2024.1382538

DOI
10.3389/fimmu.2024.1382538
Journal article

2023

Characteristics of BRCA2 families in a familial pancreatic cancer registry

Hopley, P., Downes, J., Law, J., Boughey, A., Halloran, C., & Greenhalf, W. (2023). Characteristics of BRCA2 families in a familial pancreatic cancer registry. Pancreatology, 23, e30-e31. doi:10.1016/j.pan.2023.06.479

DOI
10.1016/j.pan.2023.06.479
Journal article

Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey.

Badgery, H. E., Muhlen-Schulte, T., Zalcberg, J. R., D'souza, B., Gerstenmaier, J. F., Pickett, C., . . . Pancreatic Cancer Image Biobank Authorship Group. (2023). Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey.. HPB : the official journal of the International Hepato Pancreato Biliary Association, 25(11), 1393-1401. doi:10.1016/j.hpb.2023.07.883

DOI
10.1016/j.hpb.2023.07.883
Journal article

Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis

Eiseler, K., Neppl, L., Schmidt, A. W., Rauscher, B., Ewers, M., Masson, E., . . . Witt, H. (2023). Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis. Pancreatology, 23, e64. doi:10.1016/j.pan.2023.06.565

DOI
10.1016/j.pan.2023.06.565
Journal article

Protein expression mapping reveals molecular mechanisms in pancreatic cancer-related diabetes

Oldfield, L., Stott, M., Greenhalf, W., Halloran, C., & Costello, E. (2023). Protein expression mapping reveals molecular mechanisms in pancreatic cancer-related diabetes. Pancreatology, 23, e153. doi:10.1016/j.pan.2023.06.793

DOI
10.1016/j.pan.2023.06.793
Journal article

2022

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.

Ghaneh, P., Palmer, D., Cicconi, S., Jackson, R., Halloran, C. M., Rawcliffe, C., . . . European Study Group for Pancreatic Cancer. (2022). Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.. The lancet. Gastroenterology & hepatology, S2468-1253(22)00348-X. doi:10.1016/s2468-1253(22)00348-x

DOI
10.1016/s2468-1253(22)00348-x
Journal article

Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer

Ponweera, A., Robinson, M., Jackson, R., Halloran, C., Palmer, D., Hackert, T., . . . Ghaneh, P. (2022). Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer. In BRITISH JOURNAL OF SURGERY Vol. 109. doi:10.1093/bjs/znac404.107

DOI
10.1093/bjs/znac404.107
Conference Paper

Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

Overbeek, K. A., Poulsen, J., Lanzillotta, M., Vinge-Holmquist, O., Macinga, P., Demirci, A., . . . Rosendahl, J. (2022). Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment. Pancreatology, 22, e11-e12. doi:10.1016/j.pan.2022.06.036

DOI
10.1016/j.pan.2022.06.036
Journal article

Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer

Ponweera, A., Robinson, M., Jackson, R., Halloran, C., Palmer, D., Hackert, T., . . . Ghaneh, P. (2022). Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer. Pancreatology, 22, e58. doi:10.1016/j.pan.2022.06.149

DOI
10.1016/j.pan.2022.06.149
Journal article

Pancreatic cancer-related diabetes mellitus: a clinical perspective

Stott, M., Oldfield, L., Evans, A., Halloran, C., & Costello, E. (2022). Pancreatic cancer-related diabetes mellitus: a clinical perspective. Pancreatology, 22, e63. doi:10.1016/j.pan.2022.06.164

DOI
10.1016/j.pan.2022.06.164
Journal article

Stratified comparisons of Gemcitabine plus Capecitabine against Gemcitabine alone; further results from the ESPAC-4 trial

Jackson, R., Ghaneh, P., Halloran, C., Palmer, D., Hackert, T., Costello, E., . . . Neoptolemos, J. (2022). Stratified comparisons of Gemcitabine plus Capecitabine against Gemcitabine alone; further results from the ESPAC-4 trial. Pancreatology, 22, e79-e80. doi:10.1016/j.pan.2022.06.206

DOI
10.1016/j.pan.2022.06.206
Journal article

The Effect of Sampling Methodology upon Pancreatic Cancer Microbiome Communities

Hale, J., Evans, A., Lilley, A., Fine, D., Costello-Goldring, E., Halloran, C., . . . Greenhalf, W. (2022). The Effect of Sampling Methodology upon Pancreatic Cancer Microbiome Communities. Pancreatology, 22, e61. doi:10.1016/j.pan.2022.06.157

DOI
10.1016/j.pan.2022.06.157
Journal article

United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer

Oldfield, L., Stott, M., Hanson, R., Jackson, R. J., Reynolds, W., Chandran-Gorner, V., . . . Costello, E. (2022). United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer. BMJ OPEN, 12(10). doi:10.1136/bmjopen-2022-068010

DOI
10.1136/bmjopen-2022-068010
Journal article

A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.

Halloran, C. M., Neoptolemos, J. P., Jackson, R., Platt, K., Psarelli, E. -E., Reddy, S., . . . Ghaneh, P. (2022). A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 3(3), e198. doi:10.1097/as9.0000000000000198

DOI
10.1097/as9.0000000000000198
Journal article

SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study

Nayar, M., Varghese, C., Kanwar, A., Siriwardena, A. K., Haque, A. R., Awan, A., . . . Pandanaboyana, S. (2022). SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study. GUT, 71(7), 1444-1447. doi:10.1136/gutjnl-2021-326218

DOI
10.1136/gutjnl-2021-326218
Journal article

Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study.

de Rijk, F. E. M., van Veldhuisen, C. L., Besselink, M. G., van Hooft, J. E., van Santvoort, H. C., van Geenen, E. J. M., . . . Dutch Pancreatitis Study Group. (2022). Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22(4), 457-465. doi:10.1016/j.pan.2022.03.013

DOI
10.1016/j.pan.2022.03.013
Journal article

Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes

Oldfield, L., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T., Psarelli, E. E., . . . Costello, E. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBIOMEDICINE, 75. doi:10.1016/j.ebiom.2021.103802

DOI
10.1016/j.ebiom.2021.103802
Journal article

Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis

Moran, R. A., Halloran, C., Guo, Q., Umapathy, C., Jalaly, N. Y., Jain, S., . . . Singh, V. K. (2022). Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis. PANCREATOLOGY, 22(1), 67-73. doi:10.1016/j.pan.2021.11.003

DOI
10.1016/j.pan.2021.11.003
Journal article

2021

P-P25 Hot Axios stent removal following endoscopic pancreatic necrosectomy

Greaves, O., Baron, R., Evans, J., Raraty, M., Mann, K., Kok, K. -S., . . . Dunne, D. (2021). P-P25 Hot Axios stent removal following endoscopic pancreatic necrosectomy. British Journal of Surgery, 108(Supplement_9). doi:10.1093/bjs/znab430.248

DOI
10.1093/bjs/znab430.248
Journal article

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

Glasbey, J. C., Ademuyiwa, A., Adisa, A., AlAmeer, E., Arnaud, A. P., Ayasra, F., . . . Aldawbali, M. (2021). Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. LANCET ONCOLOGY, 22(11), 1507-1517. doi:10.1016/S1470-2045(21)00493-9

DOI
10.1016/S1470-2045(21)00493-9
Journal article

Evidence Map of Pancreatic Surgery-A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS)

Probst, P., Huettner, F. J., Meydan, O., Abu Hilal, M., Adham, M., Barreto, S. G., . . . Diener, M. K. (2021). Evidence Map of Pancreatic Surgery-A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS). SURGERY, 170(5), 1517-1524. doi:10.1016/j.surg.2021.04.023

DOI
10.1016/j.surg.2021.04.023
Journal article

Abstract 1193: Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials

Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2021). Abstract 1193: Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials. Cancer Research, 81(13_Supplement), 1193. doi:10.1158/1538-7445.am2021-1193

DOI
10.1158/1538-7445.am2021-1193
Journal article

Context specific differences in BRCA2 associated cancer risk

Law, J., Hopley, P., Sarantitis, I., Boughey, A., Pereira, S., Costello, E., . . . Greenhalf, W. (2021). Context specific differences in BRCA2 associated cancer risk. Pancreatology, 21, S62. doi:10.1016/j.pan.2021.05.163

DOI
10.1016/j.pan.2021.05.163
Journal article

How the COVID-19 pandemic has impacted participation of a pancreatic cancer screening programme

Hopley, P., Sarantitis, I., Edgington, O., Boughey, A., Halloran, C., & Greenhalf, W. (2021). How the COVID-19 pandemic has impacted participation of a pancreatic cancer screening programme. Pancreatology, 21, S81. doi:10.1016/j.pan.2021.05.220

DOI
10.1016/j.pan.2021.05.220
Journal article

Preoperative diabetes mellitus in patients undergoing pancreatic surgery

Stott, M., Crosby, B., Oldfield, L., Rao, R., Halloran, C. M., & Costello, E. (2021). Preoperative diabetes mellitus in patients undergoing pancreatic surgery. Pancreatology, 21, S53. doi:10.1016/j.pan.2021.05.143

DOI
10.1016/j.pan.2021.05.143
Journal article

Prognostic impact of CA 19-9 levels in patients with resectable pancreatic cancer who receive adjuvant chemotherapy in randomized controlled trials: A systematic review

Robinson, M., Ponweera, A., Jackson, R., Halloran, C., & Ghaneh, P. (2021). Prognostic impact of CA 19-9 levels in patients with resectable pancreatic cancer who receive adjuvant chemotherapy in randomized controlled trials: A systematic review. Pancreatology, 21, S87. doi:10.1016/j.pan.2021.05.236

DOI
10.1016/j.pan.2021.05.236
Journal article

Recruitment pathways in the UK early detection initiative (UK-EDI) for pancreatic cancer study

Stott, M., Hanson, R., Oldfield, L., Greenhalf, W., Van Der Meer, R., Allison, L., . . . Costello, E. (2021). Recruitment pathways in the UK early detection initiative (UK-EDI) for pancreatic cancer study. Pancreatology, 21, S109. doi:10.1016/j.pan.2021.05.291

DOI
10.1016/j.pan.2021.05.291
Journal article

The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer

Patel, C., Williams, D., Gana, T., Evans, A., Jackson, R., Campbell, F., . . . Costello, E. (2021). The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer. Pancreatology, 21, S69-S70. doi:10.1016/j.pan.2021.05.186

DOI
10.1016/j.pan.2021.05.186
Journal article

Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

Glasbey, J. C., Omar, O., Nepogodiev, D., Minaya-Bravo, A., Bankhead-Kendall, B. K., Fiore, M., . . . Scasso, S. (2021). Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. BRITISH JOURNAL OF SURGERY, 108(1), 88-96. doi:10.1093/bjs/znaa051

DOI
10.1093/bjs/znaa051
Journal article

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Glasbey, J. C., & Bhangu, A. (n.d.). Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. Journal of Clinical Oncology, JCO.20.01933. doi:10.1200/jco.20.01933

DOI
10.1200/jco.20.01933
Journal article

Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections.

Saunders, R., Neoptolemos, J. P., Hughes, F., Ghaneh, P., & Halloran, C. M. (2021). Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2(1), e019. doi:10.1097/as9.0000000000000019

DOI
10.1097/as9.0000000000000019
Journal article

2020

Detecting pancreatic cancer in individuals with new-onset diabetes mellitus: why and how?

Oldfield, L., Rao, R., Purewal, T., Greenhalf, W., Halloran, C., & Costello, E. (2020). Detecting pancreatic cancer in individuals with new-onset diabetes mellitus: why and how?. Pancreatology, 20(8), e2-e3. doi:10.1016/j.pan.2018.10.016

DOI
10.1016/j.pan.2018.10.016
Journal article

UK–EDI: Detecting Pancreatic Cancer with DM

Oldfield, L., Rao, R. G., Jenkinson, C., Evans, A., Purewal, T., Psarelli, E. E., . . . Costello, E. (2020). UK–EDI: Detecting Pancreatic Cancer with DM. Pancreatology, 20(8), e14. doi:10.1016/j.pan.2020.10.003

DOI
10.1016/j.pan.2020.10.003
Journal article

GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials

Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2020). GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials. In CANCER RESEARCH Vol. 80. doi:10.1158/1538-7445.PANCA20-PO-005

DOI
10.1158/1538-7445.PANCA20-PO-005
Conference Paper

PANasta Trial: Cattell Warren Versus Blumgart Techniques of Pancreatico-Jejunostomy Following Pancreato-Duodenectomy - A Randomized Double Blind Multi-Center Trial

Halloran, C. M., Neoptolemos, J. P., Jackson, R., Reddy, S., Gomez, D., O'Reilly, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren Versus Blumgart Techniques of Pancreatico-Jejunostomy Following Pancreato-Duodenectomy - A Randomized Double Blind Multi-Center Trial. In PANCREAS Vol. 49 (pp. 1411). Retrieved from https://www.webofscience.com/

Conference Paper

ESPAC-4: A randomized controlled phase III trial of adjuvant gemcitabine (GEM) and capecitabine (CAP) versus gemcitabine in resected pancreatic ductal adenocarcinoma: five year follow up.

Neoptolemos, J., Palmer, D., Gahneh, P., Valle, J., Cunningham, D., Wadsley, J., . . . Buchler, M. (2020). ESPAC-4: A randomized controlled phase III trial of adjuvant gemcitabine (GEM) and capecitabine (CAP) versus gemcitabine in resected pancreatic ductal adenocarcinoma: five year follow up.. Pancreatology, 20, S17-S18. doi:10.1016/j.pan.2020.07.393

DOI
10.1016/j.pan.2020.07.393
Journal article

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.

Sripadam, R., Mukherjee, S., Wadsley, J., Al-Mukhtar, A., Jiao, L. R., Wasan, H. S., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/

Conference Paper

PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.

Halloran, C., Neoptolemos, J. P., Platt, K., Jackson, R., Reddy, S., Oreily, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/

Conference Paper

Prevalence of diabetes mellitus among individuals undergoing pancreatic surgery

Crosby, B., Oldfield, L., Rao, R., Evans, A., Ghaneh, P., Hale, J., . . . Costello, E. (2020). Prevalence of diabetes mellitus among individuals undergoing pancreatic surgery. Pancreatology, 20, S101. doi:10.1016/j.pan.2020.07.172

DOI
10.1016/j.pan.2020.07.172
Journal article

The holding temperature of blood during a delay to processing can affect serum and plasma protein concentrations.

Small, B., Ashworth, M., Oldfield, L., Greenhalf, W., Halloran, C., & Costello-Goldring, E. (2020). The holding temperature of blood during a delay to processing can affect serum and plasma protein concentrations.. Pancreatology, 20, S120. doi:10.1016/j.pan.2020.07.217

DOI
10.1016/j.pan.2020.07.217
Journal article

UK Early Detection Initiative (UK-EDI) for Pancreatic Cancer

Oldfield, L., Hanson, R., Greenhalf, W., Meer R., V. D., Alison, L., Christiansen, P., . . . Costello, E. (2020). UK Early Detection Initiative (UK-EDI) for Pancreatic Cancer. Pancreatology, 20, S120-S121. doi:10.1016/j.pan.2020.07.218

DOI
10.1016/j.pan.2020.07.218
Journal article

Delaying surgery for patients with a previous SARS-CoV-2 infection

Delaying surgery for patients with a previous SARS-CoV-2 infection (2020). BRITISH JOURNAL OF SURGERY, 107(12), E601-E602. doi:10.1002/bjs.12050

DOI
10.1002/bjs.12050
Journal article

Early detection of pancreatic cancer

Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., . . . Costello, E. (2020). Early detection of pancreatic cancer. The Lancet Gastroenterology and Hepatology, 5(7), 698-710. doi:10.1016/S2468-1253(19)30416-9

DOI
10.1016/S2468-1253(19)30416-9
Journal article

International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club.

Mel Wilcox, C., Gress, T., Boermeester, M., Masamune, A., Lévy, P., Itoi, T., . . . International (IAP-APA-JPS-EPC) Consensus Guidelines for Chronic Pancreatitis. (2020). International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 20(5), 822-827. doi:10.1016/j.pan.2020.05.025

DOI
10.1016/j.pan.2020.05.025
Journal article

Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)

Miao, Y., Lu, Z., Yeo, C. J., Vollmer, C. M. J., Fernandez-del Castillo, C., Ghaneh, P., . . . Buchler, M. W. (2020). Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). SURGERY, 168(1), 72-84. doi:10.1016/j.surg.2020.02.018

DOI
10.1016/j.surg.2020.02.018
Journal article

International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club

Greenhalf, W., Lévy, P., Gress, T., Rebours, V., Brand, R. E., Pandol, S., . . . Neoptolemos, J. (2020). International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology. doi:10.1016/j.pan.2020.05.011

DOI
10.1016/j.pan.2020.05.011
Journal article

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.

Ghaneh, P., Palmer, D. H., Cicconi, S., Halloran, C., Psarelli, E. E., Rawcliffe, C. L., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.. In Journal of Clinical Oncology Vol. 38 (pp. 4505). American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2020.38.15_suppl.4505

DOI
10.1200/jco.2020.38.15_suppl.4505
Conference Paper

PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy—A double-blinded multi-centered trial, trial results.

Halloran, C., Neoptolemos, J. P., Platt, K., Jackson, R., Reddy, S., Oreilly, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy—A double-blinded multi-centered trial, trial results.. Journal of Clinical Oncology, 38(15_suppl), 4619. doi:10.1200/jco.2020.38.15_suppl.4619

DOI
10.1200/jco.2020.38.15_suppl.4619
Journal article

ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer

Ghaneh, P., Palmer, D., Cicconi, S., Halloran, C. M., Jackson, R., Rawcliffe, C., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer. In PANCREAS Vol. 49 (pp. 1410). Retrieved from https://www.webofscience.com/

Conference Paper

2019

Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS

Neoptolemos, J. P., Ghaneh, P., Kleeff, J., Halloran, C. M., & Büchler, M. W. (2019). Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS. ANNALS OF SURGERY, 270(06), E130-E131. doi:10.1097/SLA.0000000000003371

DOI
10.1097/SLA.0000000000003371
Journal article

The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis

Sheel, A. R. G., Baron, R. D., Dickerson, L. D., Ghaneh, P., Campbell, F., Raraty, M. G. T., . . . Neoptolemos, J. P. (2019). The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 404(7), 831-840. doi:10.1007/s00423-019-01837-3

DOI
10.1007/s00423-019-01837-3
Journal article

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Jones, R. P., Psarelli, E. -E., Jackson, R., Ghaneh, P., Halloran, C. M., Palmer, D. H., . . . Millat, B. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154(11), 1038-1048. doi:10.1001/jamasurg.2019.3337

DOI
10.1001/jamasurg.2019.3337
Journal article

Blood levels of adiponectin and IL-1Ra could facilitate earlier detection of PDAC by distinguishing individuals with type 3c diabetes from those with type 2 diabetes

Oldfield, L., Rao, R., Purewal, T., Greenhalf, W., Halloran, C., & Costello, E. (2019). Blood levels of adiponectin and IL-1Ra could facilitate earlier detection of PDAC by distinguishing individuals with type 3c diabetes from those with type 2 diabetes. Pancreatology, 19, S3. doi:10.1016/j.pan.2019.05.004

DOI
10.1016/j.pan.2019.05.004
Journal article

PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts

Barrera, L. N., Evans, A., Lane, B., Brumskill, S., Oldfield, F., Campbell, F., . . . Costello, E. (2019). PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts. Pancreatology, 19, S158. doi:10.1016/j.pan.2019.05.423

DOI
10.1016/j.pan.2019.05.423
Journal article

Patterns of cancers in families with confirmed pathogenic BRCA2 mutations

Law, J., Sarantitis, I., Boughly, A., Periera, S., Costello, E., Halloran, C., & Greenhalf, W. (2019). Patterns of cancers in families with confirmed pathogenic BRCA2 mutations. Pancreatology, 19, S66. doi:10.1016/j.pan.2019.05.169

DOI
10.1016/j.pan.2019.05.169
Journal article

A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous

Saunders, R., Ramesh, J., Cicconi, S., Evans, J., Yip, V. S., Raraty, M., . . . Halloran, C. (2019). A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 33(5), 1412-1425. doi:10.1007/s00464-018-6416-5

DOI
10.1007/s00464-018-6416-5
Journal article

Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma

Mann, K., Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2019). Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404(4), 439-449. doi:10.1007/s00423-019-01779-w

DOI
10.1007/s00423-019-01779-w
Journal article

The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Ghaneh, P., Kleeff, J., Halloran, C. M., Raraty, M., Jackson, R., Melling, J., . . . Smith, C. (2019). The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 269(03), 520-529. doi:10.1097/SLA.0000000000002557

DOI
10.1097/SLA.0000000000002557
Journal article

Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.

Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., . . . Greenhalf, W. (2019). Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.. The American Journal of Gastroenterology (Elsevier), 114(1), 155-164. doi:10.1038/s41395-018-0395-y

DOI
10.1038/s41395-018-0395-y
Journal article

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Neoptolemos, J. P., Jones, R. P., Psarelli, E. E., Jackson, R., Ghaneh, P., Halloran, C. M., . . . Buechler, M. W. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. In PANCREAS Vol. 48 (pp. 1497-1498). Retrieved from https://www.webofscience.com/

Conference Paper

hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer

Hale, J., Evans, A., Aughton, K., Elander, N. O., Ghaneh, P., Neoptolemos, J. P., . . . Greenhalf, W. (2019). hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer. In PANCREAS Vol. 48 (pp. 1436-1437). Retrieved from https://www.webofscience.com/

Conference Paper

2018

Immune Cell and Stromal Signature Associated with Progression-free Survival of Patients with Resected Pancreatic Ductal Adenocarcinoma

Mahajan, U. M., Langhoff, E., Goni, E., Costello, E., Greenhalf, W., Halloran, C. M., . . . Mayerle, J. (2018). Immune Cell and Stromal Signature Associated with Progression-free Survival of Patients with Resected Pancreatic Ductal Adenocarcinoma. Gastroenterology, 155(05), 1625-1639.E2. doi:10.1053/j.gastro.2018.08.009

DOI
10.1053/j.gastro.2018.08.009
Journal article

The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis

Sheel, A. R. G., Baron, R. D., Sarantitis, I., Ramesh, J., Ghaneh, P., Raraty, M. G. T., . . . Neoptolemos, J. P. (2018). The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis. PANCREATOLOGY, 18(7), 774-784. doi:10.1016/j.pan.2018.08.002

DOI
10.1016/j.pan.2018.08.002
Journal article

Mucinous Tumours of the Pancreas

Rao, R. G., Healey, P., & Halloran, C. M. (2018). Mucinous Tumours of the Pancreas. In Surgical Diseases of the Pancreas and Biliary Tree (pp. 311-332). Springer Singapore. doi:10.1007/978-981-10-8755-4_12

DOI
10.1007/978-981-10-8755-4_12
Chapter

18FDG PET/CT improves staging of small ≤2 cm pancreatic tumours

Mohamed, E., Sanghera, B., Wong, W., Halloran, C., & Ghaneh, P. (2018). 18FDG PET/CT improves staging of small ≤2 cm pancreatic tumours. HPB, 20, S560. doi:10.1016/j.hpb.2018.06.2024

DOI
10.1016/j.hpb.2018.06.2024
Journal article

Does tumour SUVmax predict adverse prognostic features in patients with pancreatic cancer?

Mohamed, E., Sanghera, B., Wong, W., Halloran, C., & Ghaneh, P. (2018). Does tumour SUVmax predict adverse prognostic features in patients with pancreatic cancer?. HPB, 20, S771. doi:10.1016/j.hpb.2018.06.2499

DOI
10.1016/j.hpb.2018.06.2499
Journal article

Alcohol excess and continued smoking are risk factors for progression from minimal change chronic pancreatitis to established chronic pancreatitis

Sheel, A., Baron, R., Ramesh, J., Ghaneh, P., Raraty, M., Yip, V., . . . Neoptolemos, J. (2018). Alcohol excess and continued smoking are risk factors for progression from minimal change chronic pancreatitis to established chronic pancreatitis. Pancreatology, 18(4), S103-S104. doi:10.1016/j.pan.2018.05.279

DOI
10.1016/j.pan.2018.05.279
Journal article

An endoscopic approach for pancreatic necrosis may reduce length of stay compared to minimal access surgery

Saunders, R., Ramesh, J., Griffin, R., McCready, R., Hughes, F., Evans, J., . . . Halloran, C. (2018). An endoscopic approach for pancreatic necrosis may reduce length of stay compared to minimal access surgery. Pancreatology, 18(4), S93-S94. doi:10.1016/j.pan.2018.05.253

DOI
10.1016/j.pan.2018.05.253
Journal article

Differentiation of autoimmune pancreatitis from pancreatic cancer remains challenging

Dickerson, L. D., Farooq, A., Bano, F., Kleeff, J., Halloran, C., Raraty, M., . . . Yip, V. S. (2018). Differentiation of autoimmune pancreatitis from pancreatic cancer remains challenging. Pancreatology, 18(4), S117. doi:10.1016/j.pan.2018.05.314

DOI
10.1016/j.pan.2018.05.314
Journal article

Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile

Barrera, L., Evans, A., Lane, B., Brumskill, S., Oldfield, F., Campbell, F., . . . Costello, E. (2018). Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile. Pancreatology, 18(4), S94. doi:10.1016/j.pan.2018.05.254

DOI
10.1016/j.pan.2018.05.254
Journal article

Enhanced Recovery After Surgery (ERAS) reduces the incidence of Delayed Gastric Emptying (DGE) following Pancreaticoduodenectomy

Sheel, A., Exarchou, K., Baron, R., Akintunde, V., Garry, J., Whelan, P., . . . Yip, V. (2018). Enhanced Recovery After Surgery (ERAS) reduces the incidence of Delayed Gastric Emptying (DGE) following Pancreaticoduodenectomy. Pancreatology, 18(4), S84-S85. doi:10.1016/j.pan.2018.05.227

DOI
10.1016/j.pan.2018.05.227
Journal article

Pre-operative clinical status predicts a successful enhanced recovery programme for pancreaticoduodenectomy: A single tertiary centre experience

Exarchou, K., Yip, V., Thompson, P., Kleeff, J., Garry, J., Ghaneh, P., . . . Raraty, M. (2018). Pre-operative clinical status predicts a successful enhanced recovery programme for pancreaticoduodenectomy: A single tertiary centre experience. Pancreatology, 18(4), S162-S163. doi:10.1016/j.pan.2018.05.439

DOI
10.1016/j.pan.2018.05.439
Journal article

Single incision laparoscopic surgery flank necrosectomy: A novel approach to extra-pancreatic walled off necrosis

Saunders, R., Evans, J., McCready, R., Hughes, F., Raraty, M., Yip, V., . . . Halloran, C. (2018). Single incision laparoscopic surgery flank necrosectomy: A novel approach to extra-pancreatic walled off necrosis. Pancreatology, 18(4), S170. doi:10.1016/j.pan.2018.05.459

DOI
10.1016/j.pan.2018.05.459
Journal article

The SPINK1 p.N34S variant is associated with early onset idiopathic recurrent acute pancreatitis progressing to chronic disease, but not with more rapid progression to other disease outcomes such as diabetes mellitus

Sarantitis, I., Sheel, A., Nicholson, J., McCarthy, E., Howard, E., Baron, R., . . . Greenhalf, W. (2018). The SPINK1 p.N34S variant is associated with early onset idiopathic recurrent acute pancreatitis progressing to chronic disease, but not with more rapid progression to other disease outcomes such as diabetes mellitus. Pancreatology, 18(4), S174-S175. doi:10.1016/j.pan.2018.05.471

DOI
10.1016/j.pan.2018.05.471
Journal article

The development of a Rapid Access Nurse Clinic (RANC) for benign and malignant pancreato biliary disease

Whelan, P., Garry, J., Hughes, F., McCready, R., Raraty, M., Sutton, R., . . . Halloran, C. (2018). The development of a Rapid Access Nurse Clinic (RANC) for benign and malignant pancreato biliary disease. Pancreatology, 18(4), S163. doi:10.1016/j.pan.2018.05.440

DOI
10.1016/j.pan.2018.05.440
Journal article

The influence of demographics, risk and smoking status on attendance for pancreatic cancer screening

Law, J., Sarantitis, I., Sheel, A., Costello, E., Hamady, Z., Guru, A., . . . Greenhalf, W. (2018). The influence of demographics, risk and smoking status on attendance for pancreatic cancer screening. Pancreatology, 18(4), S154-S155. doi:10.1016/j.pan.2018.05.416

DOI
10.1016/j.pan.2018.05.416
Journal article

Towards earlier detection of PDAC: Validation of a biomarker panel for the identification of type 3c diabetes among individuals newly diagnosed with type 2 diabetes

Oldfield, L., Rao, R., Purewal, T., Neoptolemos, J. P., Greenhalf, W., Halloran, C., & Costello, E. (2018). Towards earlier detection of PDAC: Validation of a biomarker panel for the identification of type 3c diabetes among individuals newly diagnosed with type 2 diabetes. Pancreatology, 18(4), S72. doi:10.1016/j.pan.2018.05.194

DOI
10.1016/j.pan.2018.05.194
Journal article

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy

Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., . . . Canc, E. S. G. P. (2018). Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118, 1084-1088. doi:10.1038/s41416-018-0005-1

DOI
10.1038/s41416-018-0005-1
Journal article

Arterial Resection in Pancreatic Cancer

Dunne, D. F. J., Kleeff, J., Yip, V. S., Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2018). Arterial Resection in Pancreatic Cancer. In Pancreatic Cancer (pp. 1089-1104). Springer New York. doi:10.1007/978-1-4939-7193-0_72

DOI
10.1007/978-1-4939-7193-0_72
Chapter

Minimally Invasive Debridement and Lavage of Necrotizing Pancreatitis

Saunders, R., Raraty, M. G. T., Halloran, C., & Neoptolemos, J. P. (2018). Minimally Invasive Debridement and Lavage of Necrotizing Pancreatitis. In Unknown Book (pp. 283-288). Wiley. doi:10.1002/9781119188421.ch31

DOI
10.1002/9781119188421.ch31
Chapter

Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial

Halloran, C. M. (2018). Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial. Annals of Surgery, 267(2), 364-369. doi:10.1097/SLA.0000000000002088

DOI
10.1097/SLA.0000000000002088
Journal article

PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality (18)fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer

Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd-Williams, H., . . . Neoptolemos, J. P. (2018). PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. HEALTH TECHNOLOGY ASSESSMENT, 22(7), 1-+. doi:10.3310/hta22070

DOI
10.3310/hta22070
Journal article

2017

The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies

Rao, R. G., Costello, E., Halloran, C. M., Oldfield, L., Greenhalf, W., Ghaneh, P., . . . Mann, K. (2017). The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies. In PANCREAS Vol. 46 (pp. 1403-1404). Retrieved from https://www.webofscience.com/

Conference Paper

Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial

Diener, M. K., Hüttner, F. J., Kieser, M., Knebe, P., Dörr-Harim, C., Distler, M., . . . Hackert, T. (2017). Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial. The Lancet, 390(10099), 1027-1037. doi:10.1016/S0140-6736(17)31960-8

DOI
10.1016/S0140-6736(17)31960-8
Journal article

A comprehensive prognostic signature based on interaction of immune cell infiltration with stromal composition for resected pancreatic ductal adenocarcinoma

Mahajan, U. M., Langhoff, E., Costello, E., Greenhalf, W., Halloran, C., Beyer, G., . . . Mayerle, J. (2017). A comprehensive prognostic signature based on interaction of immune cell infiltration with stromal composition for resected pancreatic ductal adenocarcinoma. Pancreatology, 17(3), S34. doi:10.1016/j.pan.2017.05.107

DOI
10.1016/j.pan.2017.05.107
Journal article

Cytokines as potential biomarkers for distinguishing patients with pancreatic cancer and type 2 diabetes mellitus

Rao, R. G., Oldfield, L., Evans, A., Sivapalan, L., Schuler, P., Purewal, T., . . . Costello, E. (2017). Cytokines as potential biomarkers for distinguishing patients with pancreatic cancer and type 2 diabetes mellitus. Pancreatology, 17(3), S33. doi:10.1016/j.pan.2017.05.103

DOI
10.1016/j.pan.2017.05.103
Journal article

Duodenum-preserving pancreatic head resection reduces long term pain scores and opioid analgesic use in chronic pancreatitis

Dickerson, L., Baron, R., Sheel, A., Halloran, C., Ghaneh, P., Raraty, M., . . . Neoptolemos, J. (2017). Duodenum-preserving pancreatic head resection reduces long term pain scores and opioid analgesic use in chronic pancreatitis. Pancreatology, 17(3), S90. doi:10.1016/j.pan.2017.05.284

DOI
10.1016/j.pan.2017.05.284
Journal article

Missed pancreatic ductal adenocarcinoma (PDAC) in Hereditary Pancreatitis (HP) kindreds indicate the importance of a systematic approach to secondary screening

Sheel, A., Harrison, S., Sarantitis, I., Nicholson, J., Halloran, C., Raraty, M., . . . Greenhalf, W. (2017). Missed pancreatic ductal adenocarcinoma (PDAC) in Hereditary Pancreatitis (HP) kindreds indicate the importance of a systematic approach to secondary screening. Pancreatology, 17(3), S66. doi:10.1016/j.pan.2017.05.209

DOI
10.1016/j.pan.2017.05.209
Journal article

Modelling the Tumour Microenvironment in Pancreatic Ductal Adenocarcinoma

Brumskill, S., Barrera, L., Campbell, F., Halloran, C., Neoptolemos, J., Sutton, R., . . . Costello, E. (2017). Modelling the Tumour Microenvironment in Pancreatic Ductal Adenocarcinoma. Pancreatology, 17(3), S4. doi:10.1016/j.pan.2017.05.011

DOI
10.1016/j.pan.2017.05.011
Journal article

OC-079 Role of metal vs plastic stents for endoscopic ultrasound guided drainage of peri-pancreatic fluid collections: a systematic review and meta-analysis

Ramesh, J., Saunders, R., Cicconi, S., Sutton, R., Neoptolemos, J., & Halloran, C. (2017). OC-079 Role of metal vs plastic stents for endoscopic ultrasound guided drainage of peri-pancreatic fluid collections: a systematic review and meta-analysis. Gut, 66(Suppl 2), a42. doi:10.1136/gutjnl-2017-314472.79

DOI
10.1136/gutjnl-2017-314472.79
Journal article

Risk independence for the identification of cystic lesions in Familial Pancreatic Cancer (FPC) kindreds

Sheel, A., Harrison, S., Sarantitis, I., Nicholson, J., Halloran, C., Raraty, M., . . . Greenhalf, W. (2017). Risk independence for the identification of cystic lesions in Familial Pancreatic Cancer (FPC) kindreds. Pancreatology, 17(3), S68. doi:10.1016/j.pan.2017.05.215

DOI
10.1016/j.pan.2017.05.215
Journal article

Role of metal vs plastic stents for endoscopic ultrasound guided drainage of peri-pancreatic fluid collections: A systematic review and meta-analysis

Saunders, R., Ramesh, J., Cicconi, S., Sutton, R., Neoptolemos, J., & Halloran, C. (2017). Role of metal vs plastic stents for endoscopic ultrasound guided drainage of peri-pancreatic fluid collections: A systematic review and meta-analysis. Pancreatology, 17(3), S84. doi:10.1016/j.pan.2017.05.265

DOI
10.1016/j.pan.2017.05.265
Journal article

Symptom and diabetes onset in idiopathic pancreatitis: The role of SPINK1 p.N34S mutation

Sarantitis, I., Sheel, A., Halloran, C., Mountford, R., Harrison, S., Monk, T., . . . Greenhalf, W. (2017). Symptom and diabetes onset in idiopathic pancreatitis: The role of SPINK1 p.N34S mutation. Pancreatology, 17(3), S104. doi:10.1016/j.pan.2017.05.327

DOI
10.1016/j.pan.2017.05.327
Journal article

USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES

Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES. In GUT Vol. 66 (pp. A276). doi:10.1136/gutjnl-2017-314472.538

DOI
10.1136/gutjnl-2017-314472.538
Conference Paper

Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates

Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates. Pancreatology, 17(3), S84. doi:10.1016/j.pan.2017.05.266

DOI
10.1016/j.pan.2017.05.266
Journal article

A comprehensive prognostic signature based on interaction of immune cell infiltration with stromal composition for resected pancreatic ductal adenocarcinoma

Mahajan, U. M., Langhoff, E., Costello, E., Greenhalf, W., Halloran, C., Beyer, G., . . . Mayerle, J. (n.d.). A comprehensive prognostic signature based on interaction of immune cell infiltration with stromal composition for resected pancreatic ductal adenocarcinoma. Zeitschrift für Gastroenterologie, 55(05), e1-e27. doi:10.1055/s-0037-1603060

DOI
10.1055/s-0037-1603060
Journal article

Pancreatic Anastomosis After Pancreatoduodenectomy: A Position Statement By The International Study Group Of Pancreatic Surgery (ISGPS)

Halloran, C. M. (2017). Pancreatic Anastomosis After Pancreatoduodenectomy:A Position Statement By The International Study Group Of Pancreatic Surgery (ISGPS). Surgery, 161(5), 1221-1234. doi:10.1016/j.surg.2016.11.021

DOI
10.1016/j.surg.2016.11.021
Journal article

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., . . . Büchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.. Lancet (London, England), 389(10073), 1011-1024. doi:10.1016/s0140-6736(16)32409-6

DOI
10.1016/s0140-6736(16)32409-6
Journal article

2016

Chemotherapy and radiotherapy for pancreatic cancer

Halloran, C. M., Oldfield, F. E., & Neoptolemos, J. P. (2017). Chemotherapy and radiotherapy for pancreatic cancer. In Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set (pp. 1032-1041.e3). Elsevier. doi:10.1016/b978-0-323-34062-5.00068-6

DOI
10.1016/b978-0-323-34062-5.00068-6
Chapter

Cathepsin B mediates tumor-stroma cross-talk in pancreatic cancer but its expression levels do not affect overall patient survival

Langhoff, E., Mahajan, U. M., Costello, E., Greenhalf, W., Halloran, C., Weiss, F. -U., . . . Mayerle, J. (2016). Cathepsin B mediates tumor-stroma cross-talk in pancreatic cancer but its expression levels do not affect overall patient survival. Pancreatology, 16(3), S26. doi:10.1016/j.pan.2016.05.091

DOI
10.1016/j.pan.2016.05.091
Journal article

Changes in expression of the subunits of Ribonucleotide Reductase induce gemcitabine resistance in the Suit-2 Pancreatic Cancer Cell Line

Mann, K., Melling, J., Costello, E., Halloran, C., Ghaneh, P., & Greenhalf, W. (2016). Changes in expression of the subunits of Ribonucleotide Reductase induce gemcitabine resistance in the Suit-2 Pancreatic Cancer Cell Line. Pancreatology, 16(3), S27-S28. doi:10.1016/j.pan.2016.05.095

DOI
10.1016/j.pan.2016.05.095
Journal article

Combined analysis of cytidine deaminase mRNA transcript expression with hENT1 protein expression on tissue microarrays from the ESPAC-3 trial helps predict patient survival with gemcitabine treatment

Aughton, K., Elander, N., Palmer, D., Cox, T., Campbell, F., Garner, E., . . . Greenhalf, W. (2016). Combined analysis of cytidine deaminase mRNA transcript expression with hENT1 protein expression on tissue microarrays from the ESPAC-3 trial helps predict patient survival with gemcitabine treatment. Pancreatology, 16(3), S30. doi:10.1016/j.pan.2016.05.104

DOI
10.1016/j.pan.2016.05.104
Journal article

Diabetes mellitus and tobacco smoking independently increase the risk of developing pancreatic cancer in hereditary pancreatitis (HP) in individuals from the European register for hereditary pancreatitis and pancreatic cancer (EUROPAC)

Sheel, A., Costello, E., Neoptolemos, J., Harrison, S., Lerch, M., Mayerle, J., . . . Greenhalf, W. (2016). Diabetes mellitus and tobacco smoking independently increase the risk of developing pancreatic cancer in hereditary pancreatitis (HP) in individuals from the European register for hereditary pancreatitis and pancreatic cancer (EUROPAC). Pancreatology, 16(3), S88. doi:10.1016/j.pan.2016.05.297

DOI
10.1016/j.pan.2016.05.297
Journal article

Duodenum-and spleen-preserving total pancreatectomy (DPSPTP) for end-staged chronic pancreatitis: 20 years' experience from a single pancreatic centre

Sheel, A., Baron, R., Halloran, C., Ghaneh, P., Raraty, M., Sutton, R., . . . Neoptolemos, J. (2016). Duodenum-and spleen-preserving total pancreatectomy (DPSPTP) for end-staged chronic pancreatitis: 20 years' experience from a single pancreatic centre. Pancreatology, 16(3), S86-S87. doi:10.1016/j.pan.2016.05.292

DOI
10.1016/j.pan.2016.05.292
Journal article

Identification of malignant transformation within pancreatic IPMN: A systematic review and meta-analyses

Halloran, C., Jackson, R., Gilbert, T., Psarelli, E., Cox, T., Sutton, R., . . . Neoptolemos, J. (2016). Identification of malignant transformation within pancreatic IPMN: A systematic review and meta-analyses. Pancreatology, 16(3), S99. doi:10.1016/j.pan.2016.05.333

DOI
10.1016/j.pan.2016.05.333
Journal article

Identification of novel signalling pathways dysregulated in pancreatic cancer-associated fibroblasts

Barrera, L., Lane, B., Brumskill, S., Oldfield, F., Lamond, R., Wilkinson, L., . . . Costello, E. (2016). Identification of novel signalling pathways dysregulated in pancreatic cancer-associated fibroblasts. Pancreatology, 16(3), S31. doi:10.1016/j.pan.2016.05.106

DOI
10.1016/j.pan.2016.05.106
Journal article

Misdiagnosis of chronic pancreatitis (CP) in a regional pancreas centre

Sheel, A., Halloran, C., Ghaneh, P., Kleeff, J., Raraty, M., Sutton, R., . . . Neoptolemos, J. (2016). Misdiagnosis of chronic pancreatitis (CP) in a regional pancreas centre. Pancreatology, 16(3), S94-S95. doi:10.1016/j.pan.2016.05.318

DOI
10.1016/j.pan.2016.05.318
Journal article

Outcome and survival in a single centre experience of 58 patients with duodenal adenocarcinoma undergoing pancreato-duodenectomy

Mann, K., Gilbert, T., Whelan, P., Yip, V., Halloran, C., Raraty, M., . . . Ghaneh, P. (2016). Outcome and survival in a single centre experience of 58 patients with duodenal adenocarcinoma undergoing pancreato-duodenectomy. Pancreatology, 16(3), S98-S99. doi:10.1016/j.pan.2016.05.332

DOI
10.1016/j.pan.2016.05.332
Journal article

PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value study of PET/CT in the diagnosis and management of pancreatic cancer

Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value study of PET/CT in the diagnosis and management of pancreatic cancer. Pancreatology, 16(3), S91. doi:10.1016/j.pan.2016.05.306

DOI
10.1016/j.pan.2016.05.306
Journal article

Targeted limiting dilution next-generation sequencing of p53 for the molecular detection of pancreatic ductal adenocarcinoma using pancreatic juice collected from the duodenum

Yan, L., Nicholson, J., Sheel, A., Harrison, S., Costello, E., Hanna, T., . . . Greenhalf, W. (2016). Targeted limiting dilution next-generation sequencing of p53 for the molecular detection of pancreatic ductal adenocarcinoma using pancreatic juice collected from the duodenum. Pancreatology, 16(3), S33. doi:10.1016/j.pan.2016.05.112

DOI
10.1016/j.pan.2016.05.112
Journal article

The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma

Kleeff, J., Costello, E., Jackson, R., Halloran, C., Greenhalf, W., Ghaneh, P., . . . Neoptolemos, J. P. (2016). The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Pancreatology, 16(3), S67. doi:10.1016/j.pan.2016.05.228

DOI
10.1016/j.pan.2016.05.228
Journal article

PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer

Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.4008

DOI
10.1200/JCO.2016.34.15_suppl.4008
Conference Paper

PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.

Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.. In Journal of Clinical Oncology Vol. Vol 34. Chicago: American Society of Clinical Oncology.

Conference Paper

Gemcitabine-loaded and antibody-tagged superparamagnetic iron oxide nanoparticles as targeted drug vehicles in pancreatic cancer cell lines

Nandi, S., Sykes, P. D., Hasan, E., Rubbi, C., Barrow, M., Neoptolemos, J. P., . . . Halloran, C. M. (2016). Gemcitabine-loaded and antibody-tagged superparamagnetic iron oxide nanoparticles as targeted drug vehicles in pancreatic cancer cell lines. HPB, 18, e776. doi:10.1016/j.hpb.2016.01.306

DOI
10.1016/j.hpb.2016.01.306
Journal article

PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial

Halloran, C. M., Platt, K., Gerard, A., Polydoros, F., O'Reilly, D. A., Gomez, D., . . . Ghaneh, P. (2016). PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial. TRIALS, 17. doi:10.1186/s13063-015-1144-9

DOI
10.1186/s13063-015-1144-9
Journal article

Arterial Resection in Pancreatic Cancer

Dunne, D. F. J., Kleeff, J., Yip, V. S., Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2016). Arterial Resection in Pancreatic Cancer. In Pancreatic Cancer (pp. 1-16). Springer New York. doi:10.1007/978-1-4939-6631-8_72-1

DOI
10.1007/978-1-4939-6631-8_72-1
Chapter

Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer

Gilbert, T., Baron, R., Ghaneh, P., & Halloran, C. (2016). Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer. In Pancreatic Cancer (pp. 1-17). Springer New York. doi:10.1007/978-1-4939-6631-8_80-1

DOI
10.1007/978-1-4939-6631-8_80-1
Chapter

Pancreatic cancer

Weitz, J., Büchler, M. W., Sykes, P. D., Neoptolemos, J. P., Costello, E., Halloran, C. M., . . . Allen, P. J. (2016). Pancreatic cancer. In Oxford Textbook of Oncology (pp. 478-507). Oxford University Press. doi:10.1093/med/9780199656103.003.0040

DOI
10.1093/med/9780199656103.003.0040
Chapter

Pancreatic cancer

Weitz, J., Büchler, M. W., Sykes, P. D., Neoptolemos, J. P., Costello, E., Halloran, C. M., . . . Allen, P. J. (2016). Pancreatic cancer. In Oxford Textbook of Oncology (pp. 478-507). Oxford University Press. doi:10.1093/med/9780199656103.003.0040_update_001

DOI
10.1093/med/9780199656103.003.0040_update_001
Chapter

2015

Cathepsin D expression in pancreatic ductal adenocarcinoma (PDAC) cells increases proliferation and reduces survival of pancreatic cancer patients

Mahajan, U., Langhoff, E., Costello, E., Greenhalf, W., Halloran, C., Schwaiger, T., . . . Mayerle, J. (n.d.). Cathepsin D expression in pancreatic ductal adenocarcinoma (PDAC) cells increases proliferation and reduces survival of pancreatic cancer patients. Zeitschrift für Gastroenterologie, 53(08). doi:10.1055/s-0035-1559095

DOI
10.1055/s-0035-1559095
Journal article

A single p53 mutation may predict survival in intraductal papillary mucinous neoplasms of the pancreas

Nicholson, J., Harrison, S., Yan, L., Howes, N., Hanna, T., Bullock, K., . . . Greenhalf, W. (2015). A single p53 mutation may predict survival in intraductal papillary mucinous neoplasms of the pancreas. Pancreatology, 15(3), S28-S29. doi:10.1016/j.pan.2015.05.131

DOI
10.1016/j.pan.2015.05.131
Journal article

Cathepsin D expression in pancreatic ductal adenocarcinoma (PDAC) cells increases proliferation and reduces survival of pancreatic cancer patients

Langhoff, E., Mahajan, U., Costello, E., Greenhalf, W., Halloran, C., Schwaiger, T., . . . Meyerle, J. (2015). Cathepsin D expression in pancreatic ductal adenocarcinoma (PDAC) cells increases proliferation and reduces survival of pancreatic cancer patients. Pancreatology, 15(3), S20. doi:10.1016/j.pan.2015.05.104

DOI
10.1016/j.pan.2015.05.104
Journal article

Crosstalk between hedgehog and Wnt signalling in the diseased pancreas

Brumskill, S., Barrera, L., Campbell, F., Andrews, T., Greenhalf, W., Halloran, C., . . . Costello, E. (2015). Crosstalk between hedgehog and Wnt signalling in the diseased pancreas. Pancreatology, 15(3), S26. doi:10.1016/j.pan.2015.05.123

DOI
10.1016/j.pan.2015.05.123
Journal article

Evaluation of stromal quantification in pancreatic ductal adenocarcinoma using a tissue microarray

Evans, A., Oldfield, F., Hand, K., Halloran, C., Campbell, F., Neoptolemos, J., . . . Costello, E. (2015). Evaluation of stromal quantification in pancreatic ductal adenocarcinoma using a tissue microarray. Pancreatology, 15(3), S22. doi:10.1016/j.pan.2015.05.112

DOI
10.1016/j.pan.2015.05.112
Journal article

Improved outcomes following minimal access vs open pancreatic necrosectomy in 394 patients with severe necrotizing pancreatitis. Comparison of two time periods

Gomatos, I., Halloran, C., Raraty, M., Evans, J., Ghaneh, P., Smart, H., . . . Neoptolemos, J. (2015). Improved outcomes following minimal access vs open pancreatic necrosectomy in 394 patients with severe necrotizing pancreatitis. Comparison of two time periods. Pancreatology, 15(3), S59. doi:10.1016/j.pan.2015.05.230

DOI
10.1016/j.pan.2015.05.230
Journal article

Simultaneous integration of microRNA and mRNA expression in the analysis of quiescent and activated human fibroblasts in the diseased pancreas

Barrera, L., Lane, B., Brumskill, S., Oldfield, F., Nunes, Q., Campbell, F., . . . Costello, E. (2015). Simultaneous integration of microRNA and mRNA expression in the analysis of quiescent and activated human fibroblasts in the diseased pancreas. Pancreatology, 15(3), S19-S20. doi:10.1016/j.pan.2015.05.103

DOI
10.1016/j.pan.2015.05.103
Journal article

The EUROPAC secondary screening for pancreatic cancer in familial pancreatic cancer and hereditary pancreatitis kindreds

Hanna, T., Greenhalf, W., Costello, E., Halloran, C., Ghaneh, P., Raraty, M., . . . Neoptolemos, J. (2015). The EUROPAC secondary screening for pancreatic cancer in familial pancreatic cancer and hereditary pancreatitis kindreds. Pancreatology, 15(3), S95. doi:10.1016/j.pan.2015.05.346

DOI
10.1016/j.pan.2015.05.346
Journal article

Use of gemcitabine-loaded superparamagnetic iron oxide nanoparticles against pancreatic cancer cells in an artificial circulatory model

Nandi, S., Sykes, P., Hasan, E., Barrow, M., Neoptolemos, J., Costello, E., . . . Halloran, C. (2015). Use of gemcitabine-loaded superparamagnetic iron oxide nanoparticles against pancreatic cancer cells in an artificial circulatory model. Pancreatology, 15(3), S22. doi:10.1016/j.pan.2015.05.111

DOI
10.1016/j.pan.2015.05.111
Journal article

41 Cathepsin D Expression in Pancreatic Ductal Adenocarcinoma (PDAC) Cells Increases Proliferation and Reduces Survival of Pancreatic Cancer Patients

Mahajan, U. M., Langhoff, E., Costello, E., Greenhalf, W., Halloran, C., Schwaiger, T., . . . Mayerle, J. (2015). 41 Cathepsin D Expression in Pancreatic Ductal Adenocarcinoma (PDAC) Cells Increases Proliferation and Reduces Survival of Pancreatic Cancer Patients. Gastroenterology, 148(4), S-13. doi:10.1016/s0016-5085(15)30041-x

DOI
10.1016/s0016-5085(15)30041-x
Journal article

Evidence of adjuvant chemotherapy of ductal pancreatic cancer

Sultana, A., Halloran, C., Palmer, D., Ghaneh, P., Cox, T., & Neoptolemos, J. P. (2015). Evidence of adjuvant chemotherapy of ductal pancreatic cancer. In PANCREATIC CANCER, CYSTIC NEOPLASMS, AND ENDOCRINE TUMORS: DIAGNOSIS AND MANAGEMENT (pp. 94-102). Retrieved from https://www.webofscience.com/

Chapter

Biomarkers for early diagnosis of pancreatic cancer

Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, B., . . . Costello-Goldring, E. (2015). Biomarkers for early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology, 9(03), 305-315. doi:10.1586/17474124.2015.965145

DOI
10.1586/17474124.2015.965145
Journal article

Adjuvant Therapy in Pancreatic Cancer

Oldfield, F., Ghaneh, P., Jackson, R., & Halloran, C. (n.d.). Adjuvant Therapy in Pancreatic Cancer. International Journal of Digestive Diseases, 01(01). doi:10.4172/2472-1891.100003

DOI
10.4172/2472-1891.100003
Journal article

Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.

Nicholson, J., Greenhalf, B., Jackson, R., Cox, T., Butler, J., Hanna, T., . . . Neoptolemos, J. (2015). Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.. Pancreas, 44(02), 260-265. doi:10.1097/MPA.0000000000000246

DOI
10.1097/MPA.0000000000000246
Journal article

Investigating Gemcitabine-Loaded Superparamagnetic Iron Oxide Nanoparticles Against Pancreatic Cancer Cells in Artificial Circulation

Nandi, S., Sykes, P. D., Hasan, E., Barrow, M., Costello, E., Rosseinsky, M. J., . . . Halloran, C. M. (2015). Investigating Gemcitabine-Loaded Superparamagnetic Iron Oxide Nanoparticles Against Pancreatic Cancer Cells in Artificial Circulation. PANCREAS, 44(8), 1401. Retrieved from https://www.webofscience.com/

Journal article

2014

Adjuvant therapy in pancreatic cancer

Jones, O. P., Melling, J. D., & Ghaneh, P. (2014). Adjuvant therapy in pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(40), 14733-14746. doi:10.3748/wjg.v20.i40.14733

DOI
10.3748/wjg.v20.i40.14733
Journal article

Combination therapy using a novel Plk-1 inhibitor and gemcitabine in pancreatic cancer cells

Jones, O., Greenhalf, W. B., Halloran, C., & Ghaneh, P. (2014). Combination therapy using a novel Plk-1 inhibitor and gemcitabine in pancreatic cancer cells. Pancreatology, 14(3), S21. doi:10.1016/j.pan.2014.05.444

DOI
10.1016/j.pan.2014.05.444
Journal article

PORTAL HYPERTENSION DUE TO SPLANCHNIC VENOUS THROMBOSIS FOLLOWING OPEN OR SKUNK WIRE NECROSECTOMY OF ACUTE SEVERE PANCREATITIS

Britton, E. J., Mahoney, S., Garry, J., Halloran, C., & Richardson, P. (2014). PORTAL HYPERTENSION DUE TO SPLANCHNIC VENOUS THROMBOSIS FOLLOWING OPEN OR SKUNK WIRE NECROSECTOMY OF ACUTE SEVERE PANCREATITIS. In GUT Vol. 63 (pp. S252). doi:10.1136/gutjnl-2014-307263.541

DOI
10.1136/gutjnl-2014-307263.541
Conference Paper

Serum cytokine biomarker panels for discriminating Pancreatic Cancer from Benign Pancreatic Disease

Shaw, V. E., Lane, B., Jenkinson, C., Cox, T. F., Greenhalf, W., Halloran, C. M., . . . Costello, E. (2014). Serum cytokine biomarker panels for discriminating Pancreatic Cancer from Benign Pancreatic Disease. Molecular Cancer, 13. Retrieved from https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-13-114

Journal article

Prognostic markers in acute pancreatitis

Gomatos, I. P., Xiaodong, X., Ghaneh, P., Halloran, C., Raraty, M., Lane, B., . . . Neoptolemos, J. P. (2014). Prognostic markers in acute pancreatitis. Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare, 14(3), 333-346. doi:10.1586/14737159.2014.897608

DOI
10.1586/14737159.2014.897608
Journal article

Develoment of superparamagnetic nano particles that specifically deliver intracellular chemotherapy to pancreatic cancer cell lines by antibody mediated magneto-taxis

Sykes, P. D., Nandi, S., Rossenisky, M., & Halloran, C. M. (2014). Develoment of superparamagnetic nano particles that specifically deliver intracellular chemotherapy to pancreatic cancer cell lines by antibody mediated magneto-taxis. Nature Nano.

Journal article

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Lamb, R. F., . . . Büchler, M. W. (2014). Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.. Journal of the National Cancer Institute, 106(1). doi:10.1093/jnci/djt347

DOI
10.1093/jnci/djt347
Journal article

2013

Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: A meta-analysis

Huang, W., Altaf, K., Jin, T., Xiong, J. -J., Wen, L., Javed, M. A., . . . Xia, Q. (2013). Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: A meta-analysis. WORLD JOURNAL OF GASTROENTEROLOGY, 19(28), 4607-4615. doi:10.3748/wjg.v19.i28.4607

DOI
10.3748/wjg.v19.i28.4607
Journal article

Is the association of the p.N34S SPINK1 variant explicable by a high risk halpotype rather than the polymorphism?

Nicholson, J., Grant, J., Neoptolemos, J., Harrison, S., Halloran, C., Ghaneh, P., . . . Greenhalf, W. (2013). Is the association of the p.N34S SPINK1 variant explicable by a high risk halpotype rather than the polymorphism?. Pancreatology, 13(3), S9-S10. doi:10.1016/j.pan.2013.04.026

DOI
10.1016/j.pan.2013.04.026
Journal article

Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis

Hall, A. M., Poole, L. A. L., Renton, B., Wozniak, A., Fisher, M., Neal, T., . . . Hampshire, P. A. (2013). Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis. CRITICAL CARE, 17(2). doi:10.1186/cc12569

DOI
10.1186/cc12569
Journal article

Detection of mutations in pancreatic juice collected from the duodenum by post secretin-aspiration is not reliable

Nicholson, J. A., Butler, J., Johnstone, M., Yan, L., Evans, J. C., Sarkar, S., . . . Greenhalf, W. (2013). Detection of mutations in pancreatic juice collected from the duodenum by post secretin-aspiration is not reliable. Pancreatology, 13(2), e60. doi:10.1016/j.pan.2012.12.265

DOI
10.1016/j.pan.2012.12.265
Journal article

In vitro assessment of a superparamagnetic iron oxide nanoparticle for targeting pancreatic cancer cells

Sykes, P., Olariu, C., Hasan, E., Lydon, D., Rubbi, C., Neoptolemos, J., . . . Halloran, C. (2013). In vitro assessment of a superparamagnetic iron oxide nanoparticle for targeting pancreatic cancer cells. Pancreatology, 13(2), e78. doi:10.1016/j.pan.2012.12.326

DOI
10.1016/j.pan.2012.12.326
Journal article

Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer

Nicholson, J. A., Butler, J., Harrison, S., Greenhalf, W., Sutton, R., Halloran, C., . . . Lombard, M. (2013). Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer. Pancreatology, 13(2), e60. doi:10.1016/j.pan.2012.12.264

DOI
10.1016/j.pan.2012.12.264
Journal article

Detection of mutations in pancreatic juice collected from the duodenum by post secretin-aspiration is not reliable

Nicholson, J. A., Butler, J., Johnstone, M., Yan, L., Evans, J. C., Sarkar, S., . . . Greenhalf, W. (2013). Detection of mutations in pancreatic juice collected from the duodenum by post secretin-aspiration is not reliable. Pancreatology, 13(1), e16. doi:10.1016/j.pan.2012.12.049

DOI
10.1016/j.pan.2012.12.049
Journal article

Is the Association of the p.N34S SPINK1 Variant Explicable by a High Risk Haplotype Rather Than the Polymorphism?

Nicholson, J. A., Grant, J., Johnstone, M., Harrison, S., Halloran, C. M., Raraty, M. G. T., . . . Greenhalf, W. (2013). Is the Association of the p.N34S SPINK1 Variant Explicable by a High Risk Haplotype Rather Than the Polymorphism?. In PANCREAS Vol. 42 (pp. 1372). Retrieved from https://www.webofscience.com/

Conference Paper

Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer

Nicholson, J. A., Butler, J., Harrison, S., Greenhalf, W., Sutton, R., Halloran, C., . . . Lombard, M. (2013). Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer. Pancreatology, 13(1), e9. doi:10.1016/j.pan.2012.12.027

DOI
10.1016/j.pan.2012.12.027
Journal article

Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer

Nicholson, J. A., Butler, J., Harrison, S., Greenhalf, W., Sutton, R., Halloran, C., . . . Lombard, M. (2013). Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer. Pancreatology, 13(1), e15. doi:10.1016/j.pan.2012.12.047

DOI
10.1016/j.pan.2012.12.047
Journal article

Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis.

Hall, A., Poole, L., Renton, B., Wozniak, A., Fisher, M., Neal, T., . . . Hampshire, P. A. (2013). Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis.. Crit Care, 17(2), R49.

Journal article

2012

Impact of service centralisation on outcomes for patients with pancreatic cancer

Johnstone, M., Halloran, C. M., Ghaneh, P., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. T. (2012). Impact of service centralisation on outcomes for patients with pancreatic cancer. Pancreatology, 12(6), 575. doi:10.1016/j.pan.2012.11.253

DOI
10.1016/j.pan.2012.11.253
Journal article

Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma

Melling, J., Thomas, A., Sykes, P., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2012). Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma. Pancreatology, 12(6), 585. doi:10.1016/j.pan.2012.11.285

DOI
10.1016/j.pan.2012.11.285
Journal article

Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma

Melling, J., Thomas, A., Sykes, P., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2012). Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma. Pancreatology, 12(6), 567. doi:10.1016/j.pan.2012.11.226

DOI
10.1016/j.pan.2012.11.226
Journal article

Targeting pancreatic cancer cells in vitro with super-paramagnetic iron oxide nanoparticles

Sykes, P., Olariu, C., Hasan, E., Lydon, D., Costello, E., Rubbi, C., . . . Halloran, C. (2012). Targeting pancreatic cancer cells in vitro with super-paramagnetic iron oxide nanoparticles. Pancreatology, 12(6), 548. doi:10.1016/j.pan.2012.11.160

DOI
10.1016/j.pan.2012.11.160
Journal article

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial

Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., . . . Buechler, M. W. (2012). Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 308(2), 147-156. doi:10.1001/jama.2012.7352

DOI
10.1001/jama.2012.7352
Journal article

OC-057 10 Years on from the improving outcomes guidance—development of a tertiary pancreatic cancer unit

Johnstone, M., Halloran, C. M., Ghaneh, P., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. T. (2012). OC-057 10 Years on from the improving outcomes guidance—development of a tertiary pancreatic cancer unit. Gut, 61(Suppl 2), A25.1-A25. doi:10.1136/gutjnl-2012-302514a.57

DOI
10.1136/gutjnl-2012-302514a.57
Journal article

Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer

Sykes, P. D., Neoptolemos, J. P., Costello, E., & Halloran, C. M. (2012). Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 6(3), 343-356. doi:10.1586/EGH.12.13

DOI
10.1586/EGH.12.13
Journal article

Chemotherapy and radiotherapy for pancreatic and periampullary cancer

Halloran, C. M., Ghaneh, P., & Neoptolemos, J. P. (2012). Chemotherapy and radiotherapy for pancreatic and periampullary cancer. In Blumgart's Surgery of the Liver, Pancreas and Biliary Tract (pp. 972-978.e2). Elsevier. doi:10.1016/b978-1-4377-1454-8.00063-1

DOI
10.1016/b978-1-4377-1454-8.00063-1
Chapter

Chapter 63A Chemotherapy and radiotherapy for pancreatic and periampullary cancer Adjuvant, neoadjuvant, and palliative

Halloran, C. M., Ghaneh, P., & Neoptolemos, J. P. (2012). Chapter 63A Chemotherapy and radiotherapy for pancreatic and periampullary cancer Adjuvant, neoadjuvant, and palliative. In Blumgart's Surgery of the Liver, Pancreas and Biliary Tract (pp. 972-978.e2). Elsevier. doi:10.1016/b978-1-4377-1454-8.00063-1

DOI
10.1016/b978-1-4377-1454-8.00063-1
Chapter

Molecular Biology of Pancreatic Cancer.

Sykes, P., Costello, E., Neoptolemos, J. P., & Halloran, C. M. (2012). Molecular Biology of Pancreatic Cancer.. In Oxford Textbook of Oncology (pp. TBC). Oxford: Oxford.

Chapter

2011

Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.

Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., Mcdonald, A., . . . Büchler, M. W. (2011). Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.. Journal of Clinical Oncology, 29(18_suppl), LBA4006. doi:10.1200/jco.2011.29.18_suppl.lba4006

DOI
10.1200/jco.2011.29.18_suppl.lba4006
Journal article

Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.

Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., Mcdonald, A., . . . Büchler, M. W. (2011). Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.. Journal of Clinical Oncology, 29(15_suppl), LBA4006. doi:10.1200/jco.2011.29.15_suppl.lba4006

DOI
10.1200/jco.2011.29.15_suppl.lba4006
Journal article

Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial

Diener, M. K., Seiler, C. M., Rossion, I., Kleeff, J., Glanemann, M., Butturini, G., . . . Buechler, M. W. (2011). Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. LANCET, 377(9776), 1514-1522. doi:10.1016/S0140-6736(11)60237-7

DOI
10.1016/S0140-6736(11)60237-7
Journal article

Chemotherapy and Radiotherapy: Adjuvant, Neo-Adjuvant and Palliative.

Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2011). Chemotherapy and Radiotherapy: Adjuvant, Neo-Adjuvant and Palliative.. In M. W. Buchler (Ed.), Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 5th Ed. (pp. 63A). Philadelphia: Elsevier.

Chapter

Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study

Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G. T., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study. PANCREATOLOGY, 11(6), 535-545. doi:10.1159/000333308

DOI
10.1159/000333308
Journal article

Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study

Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology, 11(6), 535-545.

Journal article

2010

Authors' reply: PBD treatment of cancer of the head of the pancreas

Neoptolemos, J. P., Lombard, M., & Halloran, C. M. (2010). Authors' reply: PBD treatment of cancer of the head of the pancreas. NATURE REVIEWS CLINICAL ONCOLOGY, 7(11). doi:10.1038/nrclinonc.2010.45-c2

DOI
10.1038/nrclinonc.2010.45-c2
Journal article

Minimal Access Retroperitoneal Pancreatic Necrosectomy <i>Improvement in Morbidity and Mortality With a Less Invasive Approach</i>

Raraty, M. G. T., Halloran, C. M., Dodd, S., Ghaneh, P., Connor, S., Evans, J., . . . Neoptolemos, J. P. (2010). Minimal Access Retroperitoneal Pancreatic Necrosectomy <i>Improvement in Morbidity and Mortality With a Less Invasive Approach</i>. ANNALS OF SURGERY, 251(5), 787-793. doi:10.1097/SLA.0b013e3181d96c53

DOI
10.1097/SLA.0b013e3181d96c53
Journal article

SURGICAL ONCOLOGY PBD-better stents in specialized centers are needed

Neoptolemos, J. P., & Halloran, C. M. (2010). SURGICAL ONCOLOGY PBD-better stents in specialized centers are needed. NATURE REVIEWS CLINICAL ONCOLOGY, 7(5), 244-246. doi:10.1038/nrclinonc.2010.45

DOI
10.1038/nrclinonc.2010.45
Journal article

ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial

Diener, M. K., Bruckner, T., Contin, P., Halloran, C., Glanemann, M., Schlitt, H. J., . . . Seiler, C. M. (2010). ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial. TRIALS, 11. doi:10.1186/1745-6215-11-47

DOI
10.1186/1745-6215-11-47
Journal article

Multifunctional nanoparticles for healthcare applications

Olariu, C. I., Yiu, H. P. P., Bouffier, L., Nedjadi, T., Costello, E., Halloran, C. M., & Rosseinsky, M. J. (2010). Multifunctional nanoparticles for healthcare applications. European Cells and Materials, 20(SUPPL.3), 192.

Journal article

Surgical oncology: PBD-better stents in specialized centers are needed, a response

Neoptolemos, J. P., Halloran, C. M., & Lombard, M. G. (2010). Surgical oncology: PBD-better stents in specialized centers are needed, a response. Nature reviews clinical oncology - submitted.

Journal article

2009

A spllen-preserving approach to pancreatic resection: Indications and complications

Gardener-Thorpe, J., Ghaneh, P., Wheelan, P., Joshi, H. M. N., Al-sarireh, B., Halloran, C. M., . . . Sutton, R. (2009). A spllen-preserving approach to pancreatic resection: Indications and complications. British Journal of Surgery.

Journal article

2008

Le taux sérique de CA 19.9 préthérapeutique permet de sélectionner les patients candidats à une laparoscopie exploratrice visant à évaluer la résécabilité des cancers pancréatiques

Halloran, C. M., Ghaneh, P., Connor, S., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. (2008). Le taux sérique de CA 19.9 préthérapeutique permet de sélectionner les patients candidats à une laparoscopie exploratrice visant à évaluer la résécabilité des cancers pancréatiques. Journal de Chirurgie, 145(4), 402. doi:10.1016/s0021-7697(08)74335-7

DOI
10.1016/s0021-7697(08)74335-7
Journal article

Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

Halloran, C. M., Ghaneh, P., Connor, S., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. T. (2008). Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. BRITISH JOURNAL OF SURGERY, 95(4), 453-459. doi:10.1002/bjs.6043

DOI
10.1002/bjs.6043
Journal article

2007

The EWTD 'triple whammy': hitting surgical trainees where it hurts

Heath, R. M., Gate, T. C. S., Halloran, C. M., Callaghan, M., Paraoan, M. T., & Blair, S. D. (2007). The EWTD 'triple whammy': hitting surgical trainees where it hurts. The Bulletin of the Royal College of Surgeons of England, 89(1), 26-28. doi:10.1308/147363507x161691

DOI
10.1308/147363507x161691
Journal article

2005

Trials of gene therapy for pancreatic carcinoma

Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma. Current Gastroenterology Reports, 7(3), 165-169. doi:10.1007/s11894-005-0028-7

DOI
10.1007/s11894-005-0028-7
Journal article

Combination Chemo-Gene Therapy for Pancreatic cancer

Halloran, C. (2005). Combination Chemo-Gene Therapy for Pancreatic cancer. (PhD Thesis, The University of Liverpool).

Thesis / Dissertation

The european working time directive 'triple whammy': Hitting trainees where it hurts

Heath, R. E., Gate, T., Halloran, C., Callaghan, M., Paraoan, M., & Blair, S. D. (2005). The european working time directive 'triple whammy': Hitting trainees where it hurts. British Journal of Surgery, 92, 113.

Journal article

Trials of gene therapy for pancreatic carcinoma.

Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma.. Current gastroenterology reports, 7(3), 165-169. doi:10.1007/s11894-005-0028-7

DOI
10.1007/s11894-005-0028-7
Journal article

2004

Current standards of surgery for pancreatic cancer

Alexakis, N., Halloran, C., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004). Current standards of surgery for pancreatic cancer. BRITISH JOURNAL OF SURGERY, 91(11), 1410-1427. doi:10.1002/bjs.4794

DOI
10.1002/bjs.4794
Journal article

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16<SUP>INK4A</SUP> greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells

Halloran, C. M., Ghaneh, P., Shore, S., Greenhalf, W., Zumstein, L., Wilson, D., . . . Costello, E. (2004). 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16<SUP>INK4A</SUP> greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. JOURNAL OF GENE MEDICINE, 6(5), 514-525. doi:10.1002/jgm.540

DOI
10.1002/jgm.540
Journal article

Novel Alternatives to Chemotherapy in Advanced Disease: Gene Transfer

Ghaneh, P., Halloran, C. M., Costello, E., & Neoptolemos, J. P. (2004). Novel Alternatives to Chemotherapy in Advanced Disease: Gene Transfer. In Pancreatic Disease (pp. 99-120). Springer London. doi:10.1007/978-1-85233-904-3_9

DOI
10.1007/978-1-85233-904-3_9
Chapter

2003

Pancreatic adenocarcinoma - gene therapy is better adjuvant treatment than chemotherapy or radiotherapy

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2003). Pancreatic adenocarcinoma - gene therapy is better adjuvant treatment than chemotherapy or radiotherapy. Pancreatology, 3(3), 245.

Journal article

2002

Complications of pancreatic cancer resection

Halloran, C. M., Ghaneh, P., Bosonnet, L., Hartley, M. N., Sutton, R., & Neoptolemos, J. P. (2002). Complications of pancreatic cancer resection. DIGESTIVE SURGERY, 19(2), 138-146. doi:10.1159/000052029

DOI
10.1159/000052029
Journal article

Complications of pancreatic cancer resection

Halloran, C. M., Ghaneh, P., Bossnett, L., Hartley, M., Sutton, R., & Neoptolemos, J. P. (2002). Complications of pancreatic cancer resection. Digestive Surgery, 19(2), 138-146. doi:10.1159/000052029

DOI
10.1159/000052029
Journal article

The combined approach of Chemo-Gene therapy in the treatment of pancreatic adenocarcinoma

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2002). The combined approach of Chemo-Gene therapy in the treatment of pancreatic adenocarcinoma. Pancreatology, 2(3), 322.

Journal article

2001

Cytotoxic drugs combined with adenoviral-mediated introduction of tumour suppresser genes act synergistically to decrease pancreatic cancer cell viability

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2001). Cytotoxic drugs combined with adenoviral-mediated introduction of tumour suppresser genes act synergistically to decrease pancreatic cancer cell viability. Pancreatology, 1(2), 164.

Journal article

The effects of combining cytotoxic agents and adenoviral mediated introduction of tumour suppresser genes on pancreatic cancer cells

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2001). The effects of combining cytotoxic agents and adenoviral mediated introduction of tumour suppresser genes on pancreatic cancer cells. Molecular Therapy, 3(5), 213-214.

Journal article

gene therapy for pancreatic cancer; cobination of cytotoxic agents with adenoviral-delivered tumour suppresser genes increases cytopathic effect

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2001). gene therapy for pancreatic cancer; cobination of cytotoxic agents with adenoviral-delivered tumour suppresser genes increases cytopathic effect. British Journal of Surgery, 88(1), 7.

Journal article

2000

An investigation into the effects, on pancreatic cancer cells, of chemotherapeutic drugs and adenoviral-mediated delivery of p53 and p16

Halloran, C., Ghaneh, P., Greenhalf, W., Neoptolemos, J. P., & Costello, E. (2000). An investigation into the effects, on pancreatic cancer cells, of chemotherapeutic drugs and adenoviral-mediated delivery of p53 and p16. Molecular Therapy, 1(5), 325-326.

Journal article

Fatal intestinal perforation secondary to fragmentation of a celestin tube

Evans, J. D., Halloran, C. M., Mansour, P., & Zeiderman, M. R. (2000). Fatal intestinal perforation secondary to fragmentation of a celestin tube. DIGESTIVE SURGERY, 17(4), 400-402. doi:10.1159/000018886

DOI
10.1159/000018886
Journal article

Gene therapy for pancreatic cancer - current and prospective strategies

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000). Gene therapy for pancreatic cancer - current and prospective strategies. SURGICAL ONCOLOGY-OXFORD, 9(4), 181-191. doi:10.1016/S0960-7404(01)00011-1

DOI
10.1016/S0960-7404(01)00011-1
Journal article

gene therapy for pancreatic cancer - current and propective strategies

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000). gene therapy for pancreatic cancer - current and propective strategies. Surgical Oncology, 9(4), 181-191.

Journal article